Brief: Moberg Pharma Divests Balmex For $4.25 Million

Moberg Pharma AB (publ)

28/02/2018 07:30

Feb 28 (Reuters) - MOBERG PHARMA AB (PUBL)  MBPH.ST : 
    * MOBERG PHARMA DIVESTS BALMEX FOR $4.25 MILLION 
    * ENTERED INTO AGREEMENT WITH RANDOB LABS TO DIVEST BRAND BALMEX FOR A TOTAL CONSIDERATION 
OF 
$4.25 MILLION (34.6 MILLION SEK) PLUS INVENTORY VALUE AT CLOSING 
    * DIVESTMENT IS EXPECTED TO RESULT IN A CAPITAL GAIN OF CIRCA $0.5 MILLION (4.4 MILLION 
SEK) 
    * TRANSACTION IS EXPECTED TO CLOSE IN APRIL 
 
Source text for Eikon:  ID:nWkr40NPD2  
Further company coverage:  MBPH.ST  
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))